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Rasagenthi Mezhugu (RGM) is a herbomineral formulation in the Siddha system of traditional medicine and is prescribed in the
southern parts of India as a remedy for all kinds of cancers. However, scientiﬁc evidence for its therapeutic eﬃcacy in cervical
cancer is lacking, and it contains heavy metals. To overcome these limitations, RGM was extracted, and the fractions were tested on
HPV-positive cervical cancer cells, ME-180 and SiHa. The extracts, free from the toxic heavy metals, aﬀected the viability of both
the cells. The chloroform fraction (cRGM) induced DNA damage and apoptosis. Mitochondria-mediated apoptosis was indicated.
Though both the cells responded to the treatment, ME-180 was more responsive. Thus, this study brings up scientiﬁc evidence for
theeﬃcacyofRGMagainsttheHPV-mediatedcervicalcancercellsand,ifthetoxicheavymetalsarethelimitationinitsuse,cRGM
would be a suitable candidate as evidence-based complementary and alternative medicine for HPV-positive cervical cancers.
1.Introduction
Cancerisoneofthemajorpublichealthproblemsworldwide
and accounts for an estimated 2.5 million cases in India
alone [1]. In the wake of resistance to chemotherapy and
the escalating toxic eﬀects of synthetic drugs/compounds,
all possible avenues are being explored to develop new and
novel anticancer drugs that will overcome these limitations.
One of the avenues is phytotherapy, which is a recognized
complementary and alternative (CAM) therapeutic modality
[2]. Many cancer patients, who are already crippled with
this disease, and further burdened by drug-induced toxic
side eﬀects, now turn to complementary and alternative
medicines hoping for a better cure or at least palliation
[3]. Herbalism is a common medical practice since time
immemorial. More than 60% of the approved drugs are
derived from nature, and most of these discoveries were
led from traditional herbal medicines [4]. The Indian
traditional systems of medicine and folk medicines make use
of thousands of plant-based formulations [5]. The principle
underlying the use of more than one plant/plant product
in these formulations is that they may produce synergistic
and/or additive eﬀects, or one may neutralize the toxic
eﬀect of another, which is otherwise therapeutic in the given
context [6].
Siddha is one among the three popular Indian traditional
medicinal systems, the other two being Ayurveda and
Unani. Siddha medicine formulations are mostly polyherbal,
but may also include metals, chemicals, and/or animal
products. The common Siddha preparations are Bhasma
(calcined metals and minerals), Churna (powders), Kashaya
(decoctions), Lehya (confections), Ghrita (ghee), Taila (oil),
and Mezhugu (wax). Rasagenthi Mezhugu (RGM), a Siddha
medicine, is a formulation containing 38 diﬀerent botanicals2 Evidence-Based Complementary and Alternative Medicine
and 8 inorganic substances, some of which are heavy metals
[7]. Siddha practitioners prescribe RGM as a therapy for
diﬀerent cancers [7]. However, scientiﬁc evidence for the
therapeutic eﬃcacy of RGM in cancer is far too limited. This
is in view of the fact that the complexity of the formulation
does not facilitate investigations in vitro. Also, the heavy
metals in RGM, mercury, lead, and arsenic, are toxic [8]. To
overcome both these limitations, a modality was developed
whereupon RGM was extracted in solvents of increasing
polarity, and the extracts were tested on cancer cell lines
[7,9].Theextractswerefoundtobefreefromthetoxicheavy
metals and amenable for in vitro testing. Thus, chloroform
fractionofRGMwasshowntobecytotoxictoprostatecancer
cell PC3 [7] and lung cancer cells A-549 and H-460 [9], and
in both cases, the cells succumbed to death by apoptosis.
Cervical cancer is one of the serious health problems in
women [10]. In India alone, more than 70,000 new cases
of cervical cancer are reported every year [1]. Most of the
cervical cancers are caused by HPV infection and integration
of HPV genome into the host cell’s genome [11]. Thus,
these cervical cancers being etiologically diﬀerent, it would
be pertinent to ﬁnd if prescription of RGM to cervical cancer
patients can have a scientiﬁc backing. Therefore, we carried
out this study to test the most eﬃcacious extractof RGM, the
chloroformextract,whichisfreefromheavymetals[7,9],on
HPV-mediated cervical cancer cell lines, ME-180 and SiHa.
In doing so, we focused on apoptosis as the end point, since
in these cervical cancer cells, the cell cycle progression and
apoptosis cascade are deregulated [12].
2.MaterialsandMethods
2.1. Preparation of RGM. Rasagenthi Mezhugu was obtained
from Indian Medical Practitioners Co-operative Phar-
macy and Stores Ltd., (IMPCOPS, Thiruvanmiyur, Chen-
nai, India), an authoritative source of Indian medicines
(http://www.impcops.org/), and its composition has been
already described [7].
2.2. Extraction of RGM. The extraction procedure also has
been previously described [7]. Brieﬂy, RGM was extracted
withmethanol(MeOH)usingSoxhletapparatus.TheMeOH
phase was evaporated under reduced pressure to obtain a
dark brown residue. This residue was suspended in water
and extracted with four organic solvents with increasing
polarity, namely, n-hexane, CHCl3,E t O A c ,a n dn-BuOH,
and the ﬁnal residue was extracted in water. All ﬁve extracts
were condensed into powder/paste under reduced pressure
using a rotary evaporator (Buchi Labortechnik AG, Flawil,
Switzerland).
2.3. Cell Culture. Human cervical cancer cells ME-180 and
SiHa were obtained from National Center for Cell Science
(NCCS), Pune, India. The cells were maintained in DMEM
medium supplemented with 10% FBS (Sigma-Aldrich,
St. Louis, Mo, USA), and with 100U/mL penicillin and
100μg/mL streptomycin as antibiotics (Himedia, Mumbai,
India) in a humidiﬁed atmosphere of 5% CO2 and 95% air
in a CO2 incubator (Heraeus, Hanau, Germany).
2.4. Cell Viability Assay. All ﬁve RGM extracts, in the
concentration range of 0–500μg/mL, dissolved in DMSO
(Sigma-Aldrich), were added to the wells, 24h after seeding
of 5 × 103 cells per well of 96-well plate. DMSO was used as
the solvent control. After 24 and 48h of incubation, 20μLo f
MTTsolution(5mg/mLinphosphate-buﬀeredsaline(PBS))
was added to each well, and the plates were wrapped with
aluminum foil and incubated for 4h at 37◦C. The purple
formazan product was dissolved by addition of 100μLo f
100% DMSO to each well. The absorbance was monitored
at 570nm (measurement) and 630nm (reference) using a
96-well plate reader (Bio-Rad, Hercules, Calif, USA). Data
were collected for four replicates each and used to calculate
the means and the standard deviations. The percentage
inhibition was calculated from this data using the following
formula:
The percentage inhibition =
Mean OD of untreated cells (control) − Mean OD of treated cells
Mean OD of untreated cells (control)
×100. (1)
From the values thus obtained, the IC50 for the respective
extracts, and for the respective durations of treatment, that
is, 24 and 48h, was deduced from the curves obtained by
plotting percentage inhibition against concentration. Since
the MTT test indicated that the chloroform extract of RGM
was the most eﬃcacious among the ﬁve extracts, and it
aﬀected the viability of the cells at concentrations very low
compared to the others, subsequent studies were limited to
this extract (cRGM).
2.5. Hoechst 33528 Staining. The cervical cancer cells ME-
1 8 0a n dS i H aw e r ec u l t u r e di n6 - w e l lp l a t e sa n dt r e a t e dw i t h
IC50 concentration of cRGM. After 24 and 48h incubation,
the treated and untreated cells were harvested and stained
with Hoechst 33258 (1mg/mL, aqueous) for 5min at room
temperature. A drop of cell suspension was placed on a glass
slide,andacoverslipwaslaidovertoreducelightdiﬀraction.
At random 300 cells, in duplicate, were observed at ×400 in
a ﬂuorescent microscope (Carl Zeiss, Jena, Germany) ﬁtted
witha377–355nmﬁlter,andthepercentageofcellsreﬂecting
pathological changes was calculated.
2.6. Acridine Orange (AO) and Ethidium Bromide (EB)
Fluorescent Assay for Cell Death. Acridine orange (AO) and
ethidium bromide (EB) staining was performed as described
by Spector et al. [13]. The cells were cultured in 6-wellEvidence-Based Complementary and Alternative Medicine 3
plates and treated with IC50 concentration of cRGM for
24 and 48h. The treated and untreated cells (25μLo f
suspension containing 5 × 105 cells) were incubated with
acridine orange and ethidium bromide solution (1 part of
100μg/mLacridineorangeand1partof100μg/mLethidium
bromideinPBS)andexaminedintheﬂuorescentmicroscope
using a UV ﬁlter (450–490nm). Three hundred cells per
sample were counted, in duplicate, for each time point (24,
48h). The cells were scored as viable or dead, and if dead,
whether by apoptosis or necrosis as judged from nuclear
morphology and cytoplasmic organization. The percentages
ofapoptoticandnecroticcellswerethencalculated.Morpho-
logical features of interest were photographed.
2.7. Single-Cell Gel Electrophoresis (Comet Assay). DNA
damage was detected by adopting the comet assay [14].
Treated (IC50 concentration; 24 and 48h treatment) and
control cells were suspended in low-melting-point agarose
in PBS and pipetted on to microscope slides precoated with
a layer of normal-melting-point agarose. The slides were
chilled on ice for 10min and then immersed in lysis solution
(2.5M NaCl, 100 × 10−3 MN a 2EDTA, 10 × 10−3 MT r i s ,
0.2 × 10−3 M NaOH, pH 10.01, and Triton X-100), and
the solution was kept overnight at 4◦C in order to lyse the
cells and to permit DNA unfolding. The slides were then
exposed to alkaline buﬀer (300 × 10−3 M NaOH, 1 × 10−3 M
Na2EDTA, pH > 13) for 20min to allow DNA unwinding.
The slides were washed with buﬀer (0.4M Tris, pH 7.5)
to neutralize excess alkali and to remove detergents, before
staining with EB. Photomicrographs were obtained using
the ﬂuorescent microscope. One hundred cells, in duplicate,
from each treatment group were digitalized and analyzed
using Comet Assay Software Program (CASP). The images
were used to estimate the DNA content of individual nuclei
and to evaluate the degree of DNA damage that represented
the fraction of total DNA in the tail.
2.8. Assay for Mitochondrial Transmembrane Potential. Mito-
chondrial transmembrane potential was assessed using the
ﬂuorescent probe JC-1, which produces green ﬂuorescence
in the cytoplasm and red-orange ﬂuorescence when accu-
mulated in healthy mitochondria. In case the mitochondrial
membrane potential is aﬀected, JC1 will be limited to
cytoplasm, and the whole cell will ﬂuoresce green. The
c e l l sw e r eg r o w ni ns i xw e l lp l a t e sa n dt r e a t e dw i t hI C 50
concentration of cRGM. After 12 and 24h exposure, the cells
were stained for 30min with JC-1 (2μg/mL) in the culture
medium. The adherent cell layer was then washed with
PBS and lifted using 250μL of trypsinEDTA. The cells were
collected in PBS, washed by centrifugation, resuspended
in 0.3mL of PBS, mixed gently, and examined in the
ﬂuorescent microscope using a UV ﬁlter (450–490nM). The
speciﬁc ﬂuorescent patterns were indicative of intact (red
ﬂuorescence) or loss (green ﬂuorescence) of mitochondrial
transmembrane potential (ΔΨm).
2.9. Annexin V-Cy3 Apoptosis Assay. Phosphatidylserine
translocation from inner to outer leaﬂet of the plasma mem-
brane is one of the early features of apoptosis. Cell surface
phosphatidylserine was detected using phosphatidylserine-
binding protein annexin V conjugated with Cy3 using the
commercially available annexin V-Cy3 apoptosis detection
kit (APOAC, Apoptosis Detection Kit, Sigma, Calif, USA).
The cells were treated with IC50 concentration of cRGM.
After 12 and 24h incubation, the cells were harvested,
centrifuged, and pellets were collected. The cell pellet was
washed with PBS and then with 1x binding buﬀer. The
washed cell pellet was suspended in 50μLo fd o u b l e -
label staining solution (Ann-Cy3 and 6-CFDA) and kept
in dark for 10min. After the incubation, the excess label
was removed by washing the cells with 1x binding buﬀer.
The annexin-Cy3 and 6-CFDA-labelled cells were observed
in the ﬂuorescent microscope. 300 cells at random were
observed. This assay facilitated detection of live cells (green),
necrotic cells (red), and apoptotic cells (red nuclei and
greencytoplasm).Thepercentageofcellsreﬂectingcelldeath
(apoptotic and necrotic, separately) was calculated. Data
were collected from two individual experiments, each in
duplicate, and used to calculate the respective means and the
standard deviations.
2.10. Statistics. N u m e r i c a ld a t aa r ee x p r e s s e da sm e a n±
standard deviation (SD). Statistical diﬀerences were eval-
uated by a one-way analysis of variance (ANOVA) using
statistical package for social sciences (SPSS) software for
window9 Version 11.5 (SPSS) Inc., Chicago, Ill, USA).
Posthoc test was performed for comparisons using the least
signiﬁcant diﬀerence (LSD) test. Diﬀerences were considered
statistically signiﬁcant when P<0.05.
3. Results
3.1. Eﬀe c to fc R G Mo nV i a b i l i t yo fC e l l sa sR e v e a l e di nM T T
Assay. MTT assay determines the integrity of mitochondria
and reﬂects the viability or otherwise of the cells. The results
of MTT assay showed that although all extracts of cRGM,
other than water extract, inhibited proliferation of both
SiHa and ME-180 cervical cancer cells in time- and dose-
dependent manner, cRGM was the most eﬃcacious since
it aﬀected viability of the cells at a concentration many
times lesser than the others (Table 1). Of the two cell types
subjectedtothetest,ME-180wasmoreresponsivethanSiHa.
Therefore, the rest of the study was limited to cRGM.
3.2.ChangesinNucleusandChromatinasRevealedinHoechst
Staining. Hoechst 33528 staining showed that there were
signiﬁcant changes in the chromatin of treated cells. In
the untreated cells, the nuclei were round, even, and homog-
enous, and the chromatin was intact. After treatment with
cRGM for 24 and 48h, the intensity of blue ﬂuorescence
emittance in respect of the treated cells was much brighter
than the control cells, and changes in the chromatin such
as condensation, marginalization, and fragmentation were
observed (Figure 1).
The nuclei were found to be abnormal in 31% and 54%
of cRGM-treated SiHa cells in the 24, 48h treatment groups,
respectively. In the case of ME-180 cell, the impact was much4 Evidence-Based Complementary and Alternative Medicine
Table 1: Inhibitory concentration (IC50)o fd i ﬀerent fractions of
R G Mi nc e r v i c a lc a n c e rc e l ll i n e s .
IC50 (μg/mL)
RGM
extract
SiHa cells ME-180 cells
24h 48h 24h 48h
Hexane 414.5±12.3 319.6±14.4 324.6±19.4 282.4±14.2
Chloroform 55.5 ±7.52 1 .6 ±5.34 0 .3 ±4.11 5 .4 ±3.2
Ethyl
acetate 441.6±22.3 324.7±16.2 373.7±21.4 347.6±15.2
Butanol 460.5±18.3 445.6±14.4 448.4±23.2 391.7±13.4
Control 24h 48h
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H
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M
E
-
1
8
0
Figure 1: Control and cRGM-treated (24h, 48h) SiHa and ME-
180 cells stained with Hoechst 33258, and arrow marks indicate
apoptotic cells.
higher, since 45% and 61% of cells were aﬀected during 24
and 48h treatment, respectively (Figure 2)
3.3. Apoptotic versus Necrotic Death Caused by the Treatment.
TheresultsobtainedwithAO&EBdoublestainingofcontrol
and treated cells are presented in the Figure 3. The control
cells ﬂuoresced uniformly green and had normal features.
Most of the cells treated with cRGM ﬂuoresced red and
indicated apoptotic features such as cell shrinkage, chro-
matin condensation, nuclear fragmentation and apoptotic
body formation. A few cells indicated necrotic features such
ascellswellingandlysis.ThoughbothSiHaandME-180cells
responded with higher incidence of apoptosis than necrosis,
the incidence of necrosis was higher in SiHa than ME-180
cells (Figure 4).
3.4. DNA Damage as Revealed in Single Cell Gel Elec-
trophoresis. In order to ﬁnd if the treatment brings about
DNA damage, which is an early event in apoptosis, single
cell gel electrophoresis (Comet assay) was conducted. After
staining with ethidium bromide and observation under
ﬂuorescent microscope (Figure 5) ,t h ec e l l sw e r es c o r e d
as dead, highly damaged, damaged, slightly damaged and
intact, and histograms were prepared using the Comet
Analysis Software (CASP) (Figure 6). The chromatin content
in the nuclear head, the length of the comet tail, and other
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Figure 2: Percentage of cells with normal and abnormal nuclei at
24 and 48h in control and cRGM-treated cells.
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Figure 3:ControlandcRGM-treated(24h,48h)SiHaandME-180
cells stained with acridine orange and ethedium bromide. Arrows
point to cells with apoptotic morphology.
comet parameters were recorded for 100 individual cells, and
theconcurrentcomparativedataweregenerated.Thoughthe
treatment caused DNA damage to both the cell types, the
response was higher in ME-180 cell than SiHa cell.
3.5. Eﬀect of cRGM on Mitochondrial Transmembrane Poten-
tial. The mitochondrial permeability transition is an impor-
tant step in the induction of cellular apoptosis. The mito-
chondrialmembranepotentialwasdetectedusingtheunique
ﬂuorescent cationic dye, JC-1. The cRGM-treated cells
showedprogressivelossofredJC-aggregateﬂuorescence,and
appearance of green monomer ﬂuorescence in the cytoplasm
at12h,andcompletelossofredﬂuorescencepresenceofonly
green ﬂuorescence at 24h (Figure 7).Evidence-Based Complementary and Alternative Medicine 5
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Figure 4: Percentage of normal, apoptotic and necrotic cells at 24
and 48h in control and cRGM-treated cells.
Control 24h 48h
S
i
H
a
M
E
-
1
8
0
Figure 5: DNA damage in cRGM-treated SiHa, and ME-180
cervical cancer cells as revealed in the comet assay. Comet images
of DNA double strand breaks at 24 and 48h treatment of cRGM.
3.6. Annexin V-Cy3 Assay. A well-established feature of an
early event in apoptosis is externalization of phosphatidyl
serine (PS) from inner to outer leaﬂet of plasma membrane.
TheresultsobtainedwithAnnexinVbindingassayofcontrol
and treated cells are represented in Figure 8.T r e a t m e n to f
SiHa cellswithcRGM caused25 and 33% of cellsto succumb
to apoptosis during 12 and 24h treatment, respectively. In
the case of ME-180 cell, the corresponding values were
higher, 43 and 54%, respectively (Figure 9). In both cell
types, a small percentage indicated reﬂections of necrosis,
and the incidence was higher with SiHa than ME 180 cells.
4. Discussion
Since ancient times, plant-based formulations have been
practiced as remedies against diverse ailments [15]. Over
the past two decades, interest in traditional medicines has
increased considerably in many parts of the world [16]. The
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Figure 6: DNA damage in SiHa and ME-180 cervical cells
populations as deﬁned according to the DNA in the tail. The
multiple parts of each column (from the bottom to the top): intact
(0–20%), slightly damaged (20–40%), damaged (40–60%), highly
damaged (60–80%), and dead (80–100%).
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Figure 7: Photomicrographs of SiHa and ME-180 cervical cancer
cells. JC-1 dye accumulates in the mitochondria of healthy cells as
aggregates (red-orange ﬂuorescing); in cells treated with the cRGM
for 12 and 24h, due to collapse of mitochondrial potential, the JC-
1 dye remained in the cytoplasm in its monomeric form, which
ﬂuoresced green.
Indian systems of medicine in general, and Ayurveda and
Siddha in particular, which originated several centuries ago,
are holistic approaches to healthcare, and RGM is one of the
fewcommonlyprescribedmedicinesforcancerintheSiddha
system. The aim of this study was to ﬁnd if the chloroform
extract of RGM, which is not only free from the toxic heavy
metal ingredients (which are removed during the extraction
process) but amenable for in vitro testing, and one which
has been already shown to be cytotoxic to PC3, A-549, and6 Evidence-Based Complementary and Alternative Medicine
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Figure 8: SiHa and ME-180 cervical cancer cells stained with annexin V-Cy3. Cells were treated with the cRGM for 12 and 24h.
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Figure 9: Percentage of SiHa and ME-180 cells in apoptosis and
necrosis, control and cRGM treated.
H-460 cancer cells, would be cytotoxic to HPV-positive cer-
vical cancer cells, and if so to infer the possible mechanism
of action.
The outcome of cytotoxicity assay in this study clearly
shows that cRGM is cytotoxic to both the HPV-positive
cervicalcancercellsandproducedtheeﬀectinverylowdoses
compared to the other extracts, as has been the case with the
prostate [7] and lung [9] cancer cells. An earlier study made
a preliminary HPLC analysis of cRGM and found about 40–
50 compounds in it [7]. Such heterogeneity would provide
for the possibility of synergistic and/or additive interactions
between the compounds, the sources of which are from
the diﬀerent herbals. Synergism, particularly, is important
because it allows lower and safer doses of each compound.
Most direct-acting natural compounds, if used alone, would
require excessive and unsafe doses to inhibit cancer [17].
The data obtained in this study strongly suggest that, when
used in combination, natural compounds can potentially
produce synergistic eﬀects in vitro. Natural compounds can
be divided into three groups: those that inhibit cancer cell
proliferation directly, those that act by indirect means to
inhibit cancer progression, and those that stimulate the
immune system [17]. There is evidence in the scientiﬁc
literature that the herbals in RGM possess properties
such as anticancer, antioxidant, detoxiﬁcation, and immune
modulation. Speciﬁcally, the following herbals possess one
or more of these property/properties: Acorus calamus [18,
19]; Alpinia galangal [20]; Azima tetracantha [21]; Celas-
trus paniculatus [22]; Cinnamomum zeylanicum [23, 24];
Clerodendron serratum [25]; Cocos nucifera [26]; Cuminum
cyminum[27];Curcumalonga[3,28];Elettariacardamomum
[24, 29]; Embelia ribes [30, 31]; Foeniculum vulgare [32, 33];
Hygrophila auriculata [34]; Myristica fragrans [35]; Nigella
sativa [3, 36, 37]; Piper longum [38]; Piper nigrum [39];
Plumbagozeylanica[40,41];Psoraleacorylifolia[42];Quercus
infectoria [43]; Saussurea lappa [44]; Semecarpus anacardium
[3, 45, 46]; Sesamum indicum [47]; Smilax china [48, 49];
Strychnos nux-vomica [50, 51]; Strychnos potatorum [52];
Terminalia chebula [53, 54]; Trachyspermum ammi [55];
Vernonia anthelmintica [56]; Vitis vinifera [57]; Withania
somnifera [58]; Zingiber oﬃcinale [59–61]. Thus, cRGM
presents a strong case for synergism as well as additivism of
the multiplicity of compounds from the 38 herbals, most of
which have been scientiﬁcally proven as associated with one
or more aspects of interference with cancer.
Theideathatanintegratedapproachisneededtomanage
cancer using the growing body of knowledge gained through
scientiﬁc developments [3] is adequately taken care of in our
approach of herbal medicine to cancer. Our ﬁnding is to be
viewed in the background that synergistic interactions occur
within a total extract of a single herb, as well as between dif-
ferent herbs in a formulation [62]. In fact, the formulations
oftraditionalmedicinesusedinChina,India,andJapanhave
been constructed to expect desirable treatment of diseases.Evidence-Based Complementary and Alternative Medicine 7
The principles are based on the interaction of several crude
drugs or several ingredients even in a single crude drug.
Therefore, the apparent combined eﬀects are equivalent to
the sum of eﬀects of those components which underwent
addition, potentiation, subtraction, and modulation [63].
Phytotherapy, the therapeutic eﬃcacy of which is based
on the combined action of a mixture of constituents, oﬀers
new treatment opportunities. Because of their biological
defense function, plant secondary metabolites act by tar-
geting and disrupting the cell membrane, by binding and
inhibiting speciﬁc proteins or they adhere to or intercalate
into RNA or DNA [64]. Cancer, by etiology, is multifactorial
in origin and, hence, it is only logical that multiple drugs are
used at a time.
The focus of the present study has been to ﬁnd if cRGM
would inhibit the proliferation of and induce apoptosis in
HPV-positive cervical cancer cells, because these are the two
major goals in cancer treatment [9]. This study provides
evidence in support of the mode of cell death is essentially
apoptosis is revealed in features such as chromatin conden-
sation, nuclear fragmentation, and formation of apoptotic
bodies. DNA fragmentation is one of the major events in
apoptosis. The result of comet assay strongly suggests that
cRGM brings about strand breaks in DNA of the cervical
cancer cells. The mitochondrial permeability transition is an
important step in the induction of cellular apoptosis, and
the results clearly suggest that cRGM leads to collapse of the
mitochondrial transmembrane potential in cervical cancer
cells. This collapse is thought to occur through formation
of pores in the mitochondria by dimerized Bax or activated
Bid, Bak, or Bad proteins. Activation of these proapoptotic
proteins is accompanied by release of cytochrome c into the
cytoplasm, which would promote the activation of caspases
which are directly responsible for apoptosis [65]. The phos-
phatidyl serine (PS) expression on the outer leaﬂet of plasma
membrane was detected with annexinV-Cy3 binding, con-
ﬁrming the early stage of apoptosis. Based on the mitochon-
drial transmembrane potential depolarization assessment,
it is reasonable to conclude that cRGM induces apoptosis
through the mitochondria-mediated pathway. Study in the
future to examine the proteins regulating mitochondria-
mediated apoptosis pathway, such as cytochrome c, Apaf-1,
adenosine triphosphate, caspase-9, caspase-8, caspase-3, and
IAP, will be highly relevant
Cervical cancer takes the lives of more than 250,000
women each year globally [66], and most of the cervical
cancers are associated with human papilloma virus (HPV)
infection [67]. The HPV 16 and 18 oncoproteins E6 and
E7 cause immortalization of the infected cells by interacting
with and degrading p53 and the cell cycle regulator proteins
such as Rb, p21, and p27 [68, 69]. Since cRGM is highly
eﬃcient in inducing death of HPV-positive cervical cancer
cells, it could be speculated that the extract might restore p53
and the cell cycle regulatory proteins to functional status by
causing degradation of viral onco-proteins, which is worthy
of investigation.
ThemajorlimitationsoftheIndiantraditionalmedicines
in presence of one or more toxic heavy metals in the prepa-
rations, some intentionally included in view of proprietary
prescription in the original formulation (as in RGM), and/or
presence of toxic heavy metals to unknown levels in the
herbals that are present in the drug. As far as the ﬁrst
is concerned, it is an established fact that the original
prescription requires thorough processing of the metal that
detoxiﬁesthemetalandmakesitintoatherapeuticsubstance
[70]. In the recent times, there is a concept that the
treatments, to which the metals are subjected to make them
intonanoparticles[70].Thereisevidencethatitispotentially
toxic when, macro- or microparticles, heavy metal could
be nontoxic and therapeutic when made into nanoparticles
[71]. It is unfortunate that some quacks try to economize
on the preparation and so do not adopt the prescribed
procedures [72]. The presence of heavy metals in the herbal
ingredients could be overcome through stringent quality
c o n t r o lm e a s u r e s[ 72]. Even assuming that the heavy metals,
present in whatever form, are not acceptable, the present
study and a few earlier studies [7, 9] show that, in spite of
thelimitationofdeviatingfromtheholismoftheproprietary
drug formulation which Regulatory Authorities of Indian
systems of medicine may object to, even after extracting out
the heavy metals RGM in the chloroform extract is potent
enough to deal with cancers, especially prostate, lung, and
cervical.
5. Conclusion
The original RGM formulation, if exonerated of heavy metal
toxicity, or cRGM, which is free from heavy metals, would be
a potential evidence-based complementary and alternative
medicine for HPV-positive cervical cancers.
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